Tag: Casirivimab/imdevimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Casirivimab/imdevimab

Are laboratory-made COVID-19-specific monoclonal antibodies effective to prevent ... - Cochrane

Added to Collection on: 2022-06-17 13:50:42

Tags for this article:

Medicine
Medical specialties
Clinical medicine
COVID-19 drug development
Monoclonal antibodies
Casirivimab/imdevimab
Bamlanivimab
SARS-CoV-2 Omicron variant
SARS-CoV-2 Delta variant
COVID-19
Post-exposure prophylaxis
Moderna COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
Patients treated with monoclonal antibodies during Covid delta surge had low rates of ...

Added to Collection on: 2022-06-27 14:40:24

Tags for this article:

Medical specialties
COVID-19 drug development
Monoclonal antibodies
Medicine
Drugs
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
SARS-CoV-2 Delta variant
SARS-CoV-2 Omicron variant
Variants of SARS-CoV-2
COVID-19
Raymund Razonable

Click the tags to see associated articles and topics

View Article Details
Should You Buy, Sell, Or Hold Roche Stock At $42? - Trefis

Added to Collection on: 2022-07-01 14:30:08

Tags for this article:

Life Sciences
Financial markets
Articles
Valuation
Roche
Drugs
Price?earnings ratio
Casirivimab/imdevimab
Stock valuation
Pharmaceutical industry in China
Biosimilar
Fundamental analysis
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Covid-19 Treatment Medicine Market scope and overview, and Opportunities up to 2028

Added to Collection on: 2022-07-12 18:19:22

Tags for this article:

Health sciences
Health
COVID-19 drug development
Occupational safety and health
Business process
Market research
Casirivimab/imdevimab
COVID-19
Pharmaceutical industry
Market share
Remdesivir

Click the tags to see associated articles and topics

View Article Details
Therapeutics and COVID-19 (Living Guideline, 14 July 2022) - World | ReliefWeb

Added to Collection on: 2022-07-14 23:58:29

Tags for this article:

Health sciences
COVID-19 drug development
Health
Drugs
Monoclonal antibodies
Occupational safety and health
Treatment and management of COVID-19
Casirivimab/imdevimab
COVID-19
SARS-CoV-2 Omicron variant
Ritonavir
COVID-19 drug repurposing research

Click the tags to see associated articles and topics

View Article Details
Regeneron ends four clinical trials of its rolled back Covid-19 antibody – Endpoints News

Added to Collection on: 2022-08-01 20:26:54

Tags for this article:

Monoclonal antibodies
Medical specialties
Life Sciences
Drugs
COVID-19 drug development
Casirivimab/imdevimab
Roche
Immunology
Regeneron Pharmaceuticals
Bamlanivimab
Treatment and management of COVID-19
Regeneron

Click the tags to see associated articles and topics

View Article Details
Covid-19 Treatment Medicine Market Growth 2022-2028: Pfizer (Paxlovid), VEKLURY ...

Added to Collection on: 2022-09-04 06:57:16

Tags for this article:

COVID-19 drug development
Life Sciences
Drugs
Health sciences
Monoclonal antibodies
Antiviral drugs
Casirivimab/imdevimab
Roche
Pfizer
Remdesivir
Regeneron Pharmaceuticals
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
Press Release: Dupixent® (dupilumab) Phase 3 Results show - GlobeNewswire

Added to Collection on: 2023-10-22 19:23:08

Tags for this article:

Sanofi
Monoclonal antibodies
Breakthrough therapy
Food and Drug Administration
Dupilumab
Eosinophilic esophagitis
Regeneron Pharmaceuticals
Prurigo nodularis
Priority review
Casirivimab/imdevimab
Esophagitis
Atopic dermatitis

Click the tags to see associated articles and topics

View Article Details
COVID drugs more often given to Medicare patients who least need them, study suggests

Added to Collection on: 2024-01-26 21:57:52

Tags for this article:

COVID-19 drug development
Treatment and management of COVID-19
Nirmatrelvir/ritonavir
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
Molnupiravir
Remdesivir
Nirmatrelvir
COVID-19
COVID-19 drug repurposing research
Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details
New Monoclonal Authorized to Prevent COVID in Immunocompromised People

Added to Collection on: 2024-03-22 22:50:07

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Immunology
AstraZeneca
Tixagevimab/cilgavimab
COVID-19
Post-exposure prophylaxis
Variants of SARS-CoV-2
Cytokine release syndrome
Casirivimab/imdevimab
Bamlanivimab/etesevimab

Click the tags to see associated articles and topics

View Article Details